Our website is set to 'allow cookies' to give you the best experience without telling us who you are. Please continue if you consent to this, or click below to change your settings:

Change settings

Find out more about our cookies policy

Resource library

Our resource library contains case studies, brochures, articles and white papers written by Sagentia’s experts

Keywords

Location

Entire Sagentia site
Resource library

Filter by sector

Narrow by resource type

Articles
Case studies
White papers
Brochures
Testimonials

Back

Article

Drug and Light Join Forces to Fight Precancerous Lesions

This article by Maria Fontanazza of MDDI (Medical Device & Diagnostic Industry) talks about the recent combination device, Cevira, from Sagentia and Photocure.

Photodynamic therapy has been available for years but generally as two separate components—the drug and the light source. Sagentia and Photocure have combined these technologies into a combination device, called Cevira, to destroy HPV-infected tissue and treat precancerous lesions on the cervix, while preserving healthy tissue. According to Peter Hillemanns, chairman of the department of obstetrics and gynecology at Medical University Hannover (Germany), the device provides the first nonsurgical treatment for HPV and precancerous cervical lesions.

Read the full article on the MDDI website.